S&P 500   5,011.12
DOW   37,775.38
QQQ   422.83
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   422.83
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   422.83
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook
S&P 500   5,011.12
DOW   37,775.38
QQQ   422.83
How major US stock indexes fared Thursday, 4/18/2024
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Shares of Walmart-backed Ibotta soar on public debut
Closing prices for crude oil, gold and other commodities
IMF's Georgieva says there's 'plenty to worry about' despite recovery for many economies
World Bank's Banga wants to make gains in tackling the effects of climate change, poverty and war
Taiwan Semiconductor Earnings: AI Dominance and Future Outlook

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
$0.02
+7.4%
$0.02
$0.01
$3.47
$1.14M1.57281,029 shs310,800 shs
CTYX
Curative Biotechnology
$0.03
$0.03
$0.00
$0.22
$10.44M-33.993.01 million shs21,466 shs
PFHOD
Pacific Health Care Organization
$1.25
-69.5%
$1.25
$1.11
$5.90
$16M0.941,720 shs2,100 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
0.00%0.00%0.00%-20.44%-99.00%
CTYX
Curative Biotechnology
-4.07%+11.92%-5.75%+3.31%+58.00%
PFHOD
Pacific Health Care Organization
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/AN/AN/AN/AN/A
CTYX
Curative Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/A
CTYX
Curative Biotechnology
N/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
$1.27M0.90N/AN/A($14.93) per share0.00
CTYX
Curative Biotechnology
N/AN/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
$6.80M2.35$0.11 per share11.21$0.63 per share1.98

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
-$58.79M-$9.23N/AN/AN/AN/AN/A-175.11%5/10/2024 (Estimated)
CTYX
Curative Biotechnology
N/AN/A0.00N/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
$1.36MN/A0.00N/A16.87%14.47%12.96%N/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/AN/AN/AN/AN/A
CTYX
Curative Biotechnology
N/AN/AN/AN/AN/A
PFHOD
Pacific Health Care Organization
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
N/A
0.07
0.07
CTYX
Curative Biotechnology
N/AN/AN/A
PFHOD
Pacific Health Care Organization
0.05
12.91
12.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
9.05%
CTYX
Curative Biotechnology
N/A
PFHOD
Pacific Health Care Organization
N/A

Insider Ownership

CompanyInsider Ownership
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
0.10%
CTYX
Curative Biotechnology
N/A
PFHOD
Pacific Health Care Organization
61.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Baudax Bio, Inc. stock logo
BXRX
Baudax Bio
952.46 million52.41 millionNot Optionable
CTYX
Curative Biotechnology
N/A388.50 millionN/ANot Optionable
PFHOD
Pacific Health Care Organization
3912.80 millionN/ANot Optionable

BXRX, PFHOD, and CTYX Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Baudax Bio logo

Baudax Bio

NASDAQ:BXRX
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.

Curative Biotechnology

OTCMKTS:CTYX
Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL.

Pacific Health Care Organization

OTCMKTS:PFHOD
Pacific Health Care Organization, Inc., together with its subsidiaries, provides specialty workers' compensation managed care services for self-administered employers, insurers, third party administrators, municipalities, and others in the United States. The company is involved in managing health care organizations (HCOs) and medical provider networks (MPNs); and negotiating legal agreements for the implementation of workers' compensation carve-outs for California clients/employers with collective bargaining units. It also offers HCO and MPN programs; medical case management services; and ancillary services, including utilization and medical bill review, lien representation, legal support, Medicare set aside, and network access services for workers' compensation claims. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Newport Beach, California.